You are here
Roche to pay more than US$1b for majority stake in tumour-testing company
THE Swiss pharmaceutical giant Roche said on Monday that it would acquire a majority of the tumour-testing company Foundation Medicine for more than US$1 billion, in a deal aimed at improving both cancer treatment and drug development.
Foundation is the leader in the
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org